Michael Wiese - Search Results

Year	Number of Results
2002	1
2003	2
2004	4
2005	7
2006	8
2007	6
2008	9
2009	10
2010	7
2011	9
2012	15
2013	19
2014	22
2015	22
2016	28
2017	22
2018	12
2019	10
2020	19
2021	23
2022	5

1

Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis.

Wiese MD, Manning-Bennett AT, Abuhelwa AY. Wiese MD, et al. Expert Opin Investig Drugs. 2020 May;29(5):475-482. doi: 10.1080/13543784.2020.1752660. Epub 2020 Apr 17. Expert Opin Investig Drugs. 2020. PMID: 32255710 Review.

2

Design of inhibitors of BCRP/ABCG2.

Juvale K, Wiese M. Juvale K, et al. Among authors: wiese m. Future Med Chem. 2015 Aug;7(12):1521-7. doi: 10.4155/fmc.15.83. Epub 2015 Aug 21. Future Med Chem. 2015. PMID: 26293476 Review.

3

Immediate-type hypersensitivity drug reactions.

Stone SF, Phillips EJ, Wiese MD, Heddle RJ, Brown SG. Stone SF, et al. Among authors: wiese md. Br J Clin Pharmacol. 2014 Jul;78(1):1-13. doi: 10.1111/bcp.12297. Br J Clin Pharmacol. 2014. PMID: 24286446 Free PMC article. Review.

4

BCRP/ABCG2 inhibitors: a patent review (2009-present).

Wiese M. Wiese M. Expert Opin Ther Pat. 2015;25(11):1229-37. doi: 10.1517/13543776.2015.1076796. Epub 2015 Aug 10. Expert Opin Ther Pat. 2015. PMID: 26291461 Review.

5

Structural feature-driven pattern analysis for multitarget modulator landscapes.

Namasivayam V, Stefan K, Silbermann K, Pahnke J, Wiese M, Stefan SM. Namasivayam V, et al. Among authors: wiese m. Bioinformatics. 2021 Dec 9;38(5):1385-92. doi: 10.1093/bioinformatics/btab832. Online ahead of print. Bioinformatics. 2021. PMID: 34888617 Free PMC article.

6

C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.

Namasivayam V, Silbermann K, Wiese M, Pahnke J, Stefan SM. Namasivayam V, et al. Among authors: wiese m. J Med Chem. 2021 Mar 25;64(6):3350-3366. doi: 10.1021/acs.jmedchem.0c02199. Epub 2021 Mar 16. J Med Chem. 2021. PMID: 33724808 Free PMC article.

7

Nuances to precision dosing strategies of targeted cancer medicines.

Hopkins AM, Menz BD, Wiese MD, Kichenadasse G, Gurney H, McKinnon RA, Rowland A, Sorich MJ. Hopkins AM, et al. Among authors: wiese md. Pharmacol Res Perspect. 2020 Aug;8(4):e00625. doi: 10.1002/prp2.625. Pharmacol Res Perspect. 2020. PMID: 32662214 Free PMC article. Review.

8

Alterations in drug disposition in older adults.

Reeve E, Wiese MD, Mangoni AA. Reeve E, et al. Among authors: wiese md. Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):491-508. doi: 10.1517/17425255.2015.1004310. Epub 2015 Jan 19. Expert Opin Drug Metab Toxicol. 2015. PMID: 25600059 Review.

9

Alterations in drug disposition in older adults: a focus on geriatric syndromes.

Maher D, Ailabouni N, Mangoni AA, Wiese MD, Reeve E. Maher D, et al. Among authors: wiese md. Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):41-52. doi: 10.1080/17425255.2021.1839413. Epub 2020 Nov 2. Expert Opin Drug Metab Toxicol. 2021. PMID: 33078628 Review.

10

The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Dias MM, Sorich MJ, Rowland A, Wiese MD, McKinnon RA. Dias MM, et al. Among authors: wiese md. Pharm Res. 2017 Aug;34(8):1544-1550. doi: 10.1007/s11095-017-2128-0. Epub 2017 Feb 24. Pharm Res. 2017. PMID: 28236061 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results